to try to deflect attention from the fact that management has savaged this operation over the past 20 years of losses. They are four-flushers and liars who create non-sense out of whole cloth and them require that I fully give my credentials to them. Not likely. We have one idiot who thinks I am his one-time EDAP co-worker "Karen". thus of course giving away the fact that he himself is an EDAP employee but strangely nobody detects that or has any problem with it. The simple fact that speaks for itself is that this management has run this company into the ground and there is ample support for that statement for anyone who merely reviews the history of consultant screw-ups, private placement sweetheart deals involving cozy underwriting and a complete joke of a PR operation. And of course there is the unassailable fact of the two decades of yearly losses despite claimed success with European operation.
Putting down you brainless idiotic company shills is like shooting fish in a barrel for me. I have always been right and you have always been wrong. Like the Harlem Globetrotters playing the Washington Generals. LOL
And not a whit of interest in this thing this morning except that the bid has dropped 7 cents. This management has not credibility. It has been good at maximizing its own reward and bestowing largesse on a few outside firms but is a total failure at really running this company. Don't you shills feel pretty stupid right about now? You certainly should. And if you think anyone is reading your drivel (such as your inane responses to my cogent posts) you really are deluding yourselves. $3 and change. How bad is that?
and very few will be needed. Say good night, oboy.
You want Sonacare? You got it. LOLOLOLOL Sonacare the all-American company leaving you EDAP whiners in the mud!
COLUMBUS, Ohio, June 14, 2016 /PRNewswire/ -- HIFU Advantage of Ohio, a partnership between Central Ohio Urology Group (COUG) and AKSM, Ltd. (AKSM) is proud to announce that it performed the first high-intensity focused ultrasound (HIFU) procedures today at Central Ohio Urology Group's main campus in Gahanna's Tech Corridor. Both physicians used the Sonablate HIFU device to perform their procedures.
That's what a price of $3.17 tells you. $90 million market cap. Ridiculous at this stage of the game. 17 consecutive years of losses. If that isn't failure, what the h--l is?
and the stock price responds as usual with a drop. Gotta love it. How much are they dropping on the useless PR firm? Let's see: Sabby, Greenleaf, PR firm, Wainwright. How many others are feeding at this trough?
life threats, solicitaion of hitmen and the general misogynistic filth posted by the disgusting Kansas City father-son team losers who are so stupid that they out themselves on an anonymous message board. He's also not at all troubled by the fact that management has failed miserably and that his stock is in the toiler. Not bloody likely that he is a real shareholder, is it?
And you all know that the most likely reason for this latest stock swoon would be that insiders know the FDA is about to stick it to them yet again. Wonder how much has now been poured down the Greenleaf rathole. Couple of mill by this time maybe? And for what?
Their stock is in the toilet due strictly to bad management and the thing that supposedly bothers them is my "negativity" in having the temerity to keep highlighting that very simple and oh, so true fact. This company should be sold to an outfit that can deliver on whatever limited promise is here and that is the point I have been making for years. This inept oboy has been an abject failure.
Glad to make your day, baturd-wrecks. You just hang here waiting for me to post and I'd hate to disappoint you. And that post by etatsruoy was indeed complete gibberish.
It was trading at over 6 when that came, remember? And the rejection was decisive.
Following relevant presentations by the company and by FDA reviewers, in addition to their own personal reviews of all of the relevant information, the members of the Gastroenterology and Urology Devices Panel voted as follows: On the question of whether the Ablatherm technology was sufficiently SAFE to warrant approval, 3/9 members voted yes; 5/9 VOTED NO; and there was one abstention.
On the question of whether the Ablatherm technology was sufficiently EFFECTIVE in the proposed therapeutic use, 9/9 members VOTED NO.
On the question of whether the risk/benefit ratio justified the use of the Ablatherm technology, 8/9 members VOTED and there was one abstention.
shell and that management is only interested in perpetuating their salaries for another ten years which will be much like the past ten. Futility purely and simply.
This management knows that. They own a pittance of shares and haven't bot any ever. They will be very content to keep drawing their unearned salaries for the next 10 years until this finally collapses.
And of course they are so utterly stupid they think they are helping the clueless management when they are doing just the opposite.